These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 808641)

  • 1. BCG immunopotentiation of an antitumor response: evidence for a cell-mediated mechanism.
    Hawrylko E
    J Natl Cancer Inst; 1975 Aug; 55(2):413-23. PubMed ID: 808641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunopotentiation with BCG: dimensions of a specific antitumor response.
    Hawrylko E
    J Natl Cancer Inst; 1975 May; 54(5):1189-97. PubMed ID: 805254
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adjuvant activity of mycobacterial fractions. III. Adjuvant effect of cell wall of Mycobacterium bovis BCG on cell-mediated cytotoxicity in mice.
    Taniyama T; Azuma I; Yamamura Y
    Jpn J Microbiol; 1975 Aug; 19(4):255-64. PubMed ID: 811834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancing effect of coenzyme, Q10 on immunorestoration with Mycobacterium bovis BCG in tumor-bearing mice.
    Kawase I; Niitani H; Saijo N; Sasaki H; Morita T
    Gan; 1978 Aug; 69(4):493-7. PubMed ID: 101414
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of tumour growth by lymphoid cells from mice treated with antilymphocyte globulin.
    Shellam GR; Fahey KJ
    Adv Exp Med Biol; 1973; 29(0):411-7. PubMed ID: 4211985
    [No Abstract]   [Full Text] [Related]  

  • 6. Potentiation of the tumor-specific immune response by Corynebacterium parvum.
    Scott MT
    J Natl Cancer Inst; 1975 Jul; 55(1):65-72. PubMed ID: 808637
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The antimetastatic function of concomitant antitumor immunity. II. Evidence that the generation of Ly-1+2+ effector T cells temporarily causes the destruction of already disseminated tumor cells.
    Dye ES
    J Immunol; 1986 Feb; 136(4):1510-5. PubMed ID: 3080526
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A stable form of delayed-type hypersensitivity.
    Lagrange PH; Mackaness GB
    J Exp Med; 1975 Jan; 141(1):82-96. PubMed ID: 1090700
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Induction of delayed-type hypersensitivity and antitumor immunity by systemic BCG.
    Hawrylko E
    Cell Immunol; 1980 Mar; 50(1):136-52. PubMed ID: 6994895
    [No Abstract]   [Full Text] [Related]  

  • 10. Delayed-type hypersensitivity and acquired resistance to plague in mice immunized with killed Yersinia pestis and immunoregulators.
    Hurtrel B; Alonso JM; Lagrange PH; Hurtrel M
    Immunology; 1981 Oct; 44(2):297-304. PubMed ID: 7028602
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific and nonspecific antitumor immunity. III. Specific T lymphocyte-mediated cytolysis of P815 mastocytoma and SL2 lymphoma by draining lymph node cells from syngeneic tumor-bearing DBA/2J mice.
    Germain RN; Williams RM; Benacerraf B
    Am J Pathol; 1976 Dec; 85(3):661-74. PubMed ID: 826167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immunological consequences of antigen overload in experimental mycobacterial infections of mice.
    Rook GA
    Clin Exp Immunol; 1975 Jan; 19(1):167-77. PubMed ID: 1106912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunopotentiation with BCG. II. Modulation of the response to sheep red blood cells.
    Miller TE; Mackaness GB; Lagrange PH
    J Natl Cancer Inst; 1973 Nov; 51(5):1669-76. PubMed ID: 4587141
    [No Abstract]   [Full Text] [Related]  

  • 14. Intradermal and oral immunization with recombinant Mycobacterium bovis BCG expressing the simian immunodeficiency virus Gag protein induces long-lasting, antigen-specific immune responses in guinea pigs.
    Kawahara M; Matsuo K; Honda M
    Clin Immunol; 2006 Apr; 119(1):67-78. PubMed ID: 16386958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A long-lasting enhancing effect of anti-tuberculin antiserum on delayed-type hypersensitivity reaction in BCG-infected guinea pigs.
    Mauch H; Hammer HJ; Kümel G
    Immunobiology; 1980 Jan; 156(4-5):477-82. PubMed ID: 6989751
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Strain difference in delayed-type hypersensitivity to BCG in mice: role of splenic adherent cells in the primary immune response.
    Nakamura RM; Tanaka H; Tokunaga T
    Immunology; 1982 Dec; 47(4):729-31. PubMed ID: 6216204
    [No Abstract]   [Full Text] [Related]  

  • 17. Histopathology of tumor regression after intralesional injection of Mycobacterium bovis. IV. Development of immunity to tumor cells and BCG.
    Hanna MG; Snodgrass MJ; Zbar B; Rapp HJ
    J Natl Cancer Inst; 1973 Dec; 51(6):1897-908. PubMed ID: 4358147
    [No Abstract]   [Full Text] [Related]  

  • 18. Cellular and humoral immunity to leukemia cells in BCG-induced growth control of a murine leukemia.
    Olsson L; Florentin I; Kiger N; Mathé G
    J Natl Cancer Inst; 1977 Oct; 59(4):1297-306. PubMed ID: 904001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects on tumor growth in vivo by manipulation of the tumor immune response.
    Sjögren HO
    Johns Hopkins Med J Suppl; 1974; 3():51-60. PubMed ID: 4370816
    [No Abstract]   [Full Text] [Related]  

  • 20. In vitro induction of suppressor T-cells in delayed-type hypersensitivity to BCG and an essential role of I-J positive accessory cells.
    Nakamura RM; Tanaka H; Tokunaga T
    Immunol Lett; 1982 Jun; 4(6):295-9. PubMed ID: 6214504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.